A DGOG open-label multicenter phase II study of pazopanib in metastatic and locally advanced hormone-resistant endometrial cancer

L. E. Boom, P. B. Ottevanger, A. Reyners, J. R. Kroep, P. Witteveen, R. Lalisang, A. M. Westermann

Research output: Contribution to journal › Article › Academic › peer-review

Access to Document

@article{d5b382a5bea74793b41ff3c8c221119c,

title = "A DGOG open-label multicenter phase II study of pazopanib in metastatic and locally advanced hormone-resistant endometrial cancer",

author = "Boom, {L. E.} and Ottevanger, {P. B.} and A. Reyners and Kroep, {J. R.} and P. Witteveen and R. Lalisang and Westermann, {A. M.}",

year = "2016",

doi = "https://doi.org/10.1093/annonc/mdw374.05",

language = "English",

volume = "27",

pages = "vi297",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - A DGOG open-label multicenter phase II study of pazopanib in metastatic and locally advanced hormone-resistant endometrial cancer

AU - Boom, L. E.

AU - Ottevanger, P. B.

AU - Reyners, A.

AU - Kroep, J. R.

AU - Witteveen, P.

AU - Lalisang, R.

AU - Westermann, A. M.

PY - 2016

Y1 - 2016

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85083629801&origin=inward

U2 - https://doi.org/10.1093/annonc/mdw374.05

DO - https://doi.org/10.1093/annonc/mdw374.05

M3 - Article

SN - 0923-7534

VL - 27

SP - vi297

JO - Annals of Oncology

JF - Annals of Oncology

ER -